Therapeutic applications of curcumin for patients with pancreatic cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  World Journal of Gastroenterology

• Publication date

  2014-07-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.3748/wjg.v20.i28.9384PMID 25071333PMCID PMC4110570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Encapsulation of curcumin into layered double hydroxides

  2014cited by this paper
• Upregulation of extrinsic apoptotic pathway in curcumin‐mediated antiproliferative effect on human pancreatic carcinogenesis

  2013cited by this paper
• Novel Curcumin-Loaded Magnetic Nanoparticles for Pancreatic Cancer Treatment

  2013cited by this paper
• Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study.

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients

  2013cited by this paper
• The Potential Role of Curcumin for Treatment of Pancreatic Cancer

  2012cited by this paper
• Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer.

  2012cited by this paper
• Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study.

  2012cited by this paper
• Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway

  2012cited by this paper
• Synergistic Effect of Curcumin and Cisplatin via Down-Regulation of Thymidine Phosphorylase and Excision Repair Cross-Complementary 1 (ERCC1)

  2011cited by this paper
• A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

  2011cited by this paper
• Curcumin ameliorates oxaliplatin‐induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo

  2011cited by this paper
• 「緩和ケア」として行われた介入と副次的評価項目であることの限界 (論文を読み,理解する--Early palliative care for patients with metastatic non-small-cell lung cancer)

  2011cited by this paper
• Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers

  2011cited by this paper
• Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells

  2011cited by this paper
• Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.

  2011cited by this paper
• Curcumin analog GO‐Y030 is a novel inhibitor of IKKβ that suppresses NF‐κB signaling and induces apoptosis

  2011cited by this paper
• Innovative preparation of curcumin for improved oral bioavailability.

  2011cited by this paper
• Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin.

  2010cited by this paper
• Development of multiple-layer polymeric particles for targeted and controlled drug delivery.

  2010cited by this paper
• Early palliative care for patients with metastatic non-small-cell lung cancer.

  2010cited by this paper
• Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer

  2010cited by this paper
• Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.

  2010cited by this paper
• Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation*

  2010cited by this paper
• Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells.

  2010cited by this paper
• Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

  2010cited by this paper
• Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKKβ Protein of the NFκB Pathway

  2010cited by this paper
• Advanced pancreatic carcinoma: current treatment and future challenges

  2010cited by this paper
• Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin.

  2009cited by this paper
• Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells

  2009cited by this paper
• Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

  2009cited by this paper
• Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.

  2009cited by this paper
• Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?

  2009cited by this paper
• Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

  2009cited by this paper
• Curcumin Inhibits Constitutive STAT3 Phosphorylation in Human Pancreatic Cancer Cell lines and Downregulation of Survivin/BIRC5 Gene Expression

  2009cited by this paper
• Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model.

  2009cited by this paper
• Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.

  2009cited by this paper
• Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials

  2008cited by this paper
• Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects

  2008cited by this paper
• A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95®CG (Biocurcumax™), A Novel Bioenhanced Preparation of Curcumin

  2008cited by this paper
• Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.

  2008cited by this paper
• Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

  2008cited by this paper
• MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival

  2008cited by this paper
• Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB.

  2008cited by this paper
• Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells.

  2008cited by this paper
• Curcumin Sensitizes Human Colorectal Cancer Xenografts in Nude Mice to γ-Radiation by Targeting Nuclear Factor-κB–Regulated Gene Products

  2008cited by this paper
• Loading of curcumin into macrophages using lipid-based nanoparticles.

  2008cited by this paper
• Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy

  2007cited by this paper
• Highly active anticancer curcumin analogues.

  2007cited by this paper
• Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

  2007cited by this paper
• Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

  2007cited by this paper
• Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway

  2007cited by this paper
• Curcumin: the Indian solid gold.

  2007cited by this paper
• Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.

  2007cited by this paper
• Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.

  2007cited by this paper
• Preclinical assessment of curcumin as a potential therapy for B‐CLL

  2007cited by this paper
• Molecular understanding and modern application of traditional medicines: triumphs and trials.

  2007cited by this paper
• Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.

  2006cited by this paper
• Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin.

  2006cited by this paper
• Retracted: Notch‐1 down‐regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells

  2006cited by this paper
• Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.

  2006cited by this paper
• Retracted: Curcumin (diferuloylmethane) inhibits constitutive active NF‐κB, leading to suppression of cell growth of human T‐cell leukemia virus type I‐infected T‐cell lines and primary adult T‐cell leukemia cells

  2006cited by this paper
• Liposome‐encapsulated curcumin

  2005cited by this paper
• Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

  2005cited by this paper
• Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.

  2005cited by this paper
• Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis

  2005cited by this paper
• A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.

  2005cited by this paper
• Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.

  2005cited by this paper
• Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.

  2004cited by this paper
• Phase I Clinical Trial of Oral Curcumin

  2004cited by this paper
• Nuclear factor‐κB and IκB kinase are constitutively active in human pancreatic cells, and their down‐regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis

  2004cited by this paper
• Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.

  2002cited by this paper
• Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

  2001cited by this paper
• Interpreting the significance of changes in health-related quality-of-life scores.

  1998cited by this paper
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

  1997cited by this paper
• Bmc Complementary and Alternative Medicine Dose Escalation of a Curcuminoid Formulation

  year unknowncited by this paper
• Cited Articles Citing Articles E-mail Alerts Curcumin, a Dietary Component, Has Anticancer, Chemosensitization, and Radiosensitization Effects by Down-regulating the Mdm2 Oncogene through the Pi3k/mtor/ets2 Pathway

  year unknowncited by this paper

• Targeting the Autophagy–Apoptosis Axis in Osteosarcoma: Therapeutic Potential of Biocompounds: A Review

  2026cites this paper
• Telomeres, Telomerase, and Curcumin: A New Frontier in Cancer Therapy: A Narrative Review

  2025cites this paper
• Curcumin-loaded nanotheranostics for cancer therapy: Advances in biosensing, imaging, and multimodal therapy

  2025cites this paper
• PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy

  2025cites this paper
• Unveiling the mechanisms and promising molecular targets of curcumin in pancreatic cancer through multi-dimensional data

  2025cites this paper
• Nanoparticle-based delivery systems for phytochemicals in cancer therapy: molecular mechanisms, clinical evidence, and emerging trends

  2025cites this paper
• Potential of curcumin and its derivatives, modern insights on the anticancer properties: a comprehensive overview

  2025cites this paper
• Insights into curcumin's anticancer activity in pancreatic ductal adenocarcinoma: Experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1.

  2025cites this paper
• TURMERIC’S HEALING TOUCH: EXPLORING CURCUMIN’S MEDICAL RENAISSANCE

  2024cites this paper
• Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy?

  2023cites this paper
• Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives.

  2023cites this paper
• Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer – An Overview

  2023cites this paper
• Curcumin: a bioactive compound with molecular targets for human malignancies

  2023cites this paper
• Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients

  2023cites this paper
• Dual Action of Curcumin as an Anti- and Pro-Oxidant from a Biophysical Perspective

  2023cites this paper
• Theracurmin Modulates Cardiac Inflammation in Experimental Model of Trypanosoma cruzi Infection

  2023cites this paper
• Pyroptosis, Metabolism, and Oxidation in Tumorigenesis: Mechanisms and Therapeutic Implications

  2023cites this paper
• The anticancer, anti-oxidant, and antibacterial activities of chitosan-lecithin-coated parthenolide/tyrosol hybrid nanoparticles

  2023cites this paper
• MTH-3 sensitizes oral cancer cells to cisplatin via regulating TFEB.

  2022cites this paper
• MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer

  2022cites this paper
• Alginate-Based Nanosystems for Therapeutic Applications

  2022cites this paper
• Therapeutic potency of curcumin for allergic diseases: A focus on immunomodulatory actions.

  2022cites this paper
• Mechanistic insights and docking studies of phytomolecules as potential candidates in the management of cancer.

  2022cites this paper
• Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches

  2022cites this paper
• The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years

  2022cites this paper
• Involvement of microRNA modifications in anticancer effects of major polyphenols from green tea, coffee, wine, and curry

  2022cites this paper
• Gastrointestinal Tumors: Phytochemical and Drug Combinations Targeting the Hallmarks of Cancer

  2021cites this paper
• Targeting Wnt Signaling in Endometrial Cancer

  2021cites this paper
• Molecular simulation of curcumin loading on graphene and graphene oxide for drug delivery applications

  2021cites this paper
• Apoptotic Pathway

  2021cites this paper
• Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence

  2021cites this paper
• Targeting Endoplasmic Reticulum Stress as an Effective Treatment for Alcoholic Pancreatitis

  2021cites this paper
• Protective effect of the association of curcumin with piperine on prostatic lesions: New perspectives on BPA-induced carcinogenesis.

  2021cites this paper
• Development and Evaluation of Curcumin Liquid Crystal Systems for Cervical Cancer

  2020cites this paper
• Overcoming cancer therapeutic bottleneck by drug repurposing

  2020cites this paper
• SB365 induces apoptosis and suppresses proliferation of glioblastoma cells

  2020cites this paper
• Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines

  2020cites this paper
• Molecular mechanisms linking environmental toxicants to cancer development: Significance for protective interventions with polyphenols.

  2020cites this paper
• Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management

  2020cites this paper
• Curcumin: A therapeutic potential in ageing-related disorders

  2020cites this paper
• Enhanced anti‐tumor effects of the PD‐1 blockade combined with a highly absorptive form of curcumin targeting STAT3

  2020cites this paper
• Carrier‐Free Nanoassembly of Curcumin–Erlotinib Conjugate for Cancer Targeted Therapy

  2020cites this paper
• miR-421 up-regulation by the oleanolic acid derivative K73-03 regulates epigenetically SPINK1 transcription in pancreatic cancer cells leading to metabolic changes and enhanced apoptosis.

  2020cites this paper
• Bisphosphonate-functionalized micelles for targeted delivery of curcumin to metastatic bone cancer

  2020cites this paper
• Synergistic effect of coumarine derivatives imperatorin and osthol on 5-fluorourasil cytotoxicity on nonsmall cell lung cancer cells

  2019cites this paper
• Potential Therapeutic Agents Against Par-4 Target for Cancer Treatment: Where Are We Going?

  2019cites this paper
• Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma

  2019cites this paper
• Super-enhancers: novel target for pancreatic ductal adenocarcinoma

  2019cites this paper
• A Systematic Review and Meta-analysis of Randomized Controlled Trials on the Effects of Turmeric and Curcuminoids on Blood Lipids in Adults with Metabolic Diseases.

  2019cites this paper
• A novel curcumin analog inhibits canonical and non-canonical functions of telomerase through STAT3 and NF-κB inactivation in colorectal cancer cells

  2019cites this paper
• Targeting protein kinase inhibitors with Traditional Chinese Medicine.

  2019cites this paper
• The Nanoformulations of Curcumin for Cancer Therapy: New Perspectives

  2019cites this paper
• Curcumin-Loaded Nanoparticles and Their Potential as Anticancer Agents in Breast Cancer

  2019cites this paper
• Molecular Mechanisms of Curcumin and Its Analogs in Colon Cancer Prevention and Treatment.

  2019cites this paper
• Curcumin in Food

  2019cites this paper
• Naturally occurring compounds as pancreatic cancer therapeutics

  2018cites this paper
• Clinical safety and efficacy of curcumin use for oral lichen planus: a systematic review

  2018cites this paper
• Potential therapeutic effects of curcumin in gastric cancer

  2018cites this paper
• Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin

  2018cites this paper
• Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells

  2018cites this paper
• Synthesis of novel Chlorin e6-curcumin conjugates as photosensitizers for photodynamic therapy against pancreatic carcinoma.

  2018cites this paper
• Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer.

  2018cites this paper
• Apoptosis: A Target for Anticancer Therapy

  2018cites this paper
• Curcumin in Cancer Prevention

  2018cites this paper
• Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression

  2018cites this paper
• Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial

  2018cites this paper
• Spices and Odorants as TRP Channel Activators

  2017cites this paper
• Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs

  2017cites this paper
• Effectiveness of Curcumin for Treating Cancer During Chemotherapy

  2017cites this paper
• In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.

  2017cites this paper
• Nanotechnological Approaches for Enhancing the Oral Bioavailability of Curcumin

  2017cites this paper
• The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review

  2017cites this paper
• Potent effects of dioscin against pancreatic cancer via miR‐149‐3P‐mediated inhibition of the Akt1 signalling pathway

  2017cites this paper
• Oncogenic KRAS and the Inflammatory Micro-Environment in Pancreatic Cancer

  2017cites this paper
• Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells

  2017cites this paper
• Pancreatic Cancer, Pancreatitis, and Oxidative Stress

  2017cites this paper
• Curcumin suppresses epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells by inhibiting cancer-associated fibroblasts.

  2017cites this paper
• An Argument to Examine Exosomal Survivin Splice Variant Expression and Patient Survival in Pancreatic Cancer

  2017cites this paper
• Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells

  2017cites this paper
• Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms

  2017cites this paper
• Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic cancer cells

  2017cites this paper
• Nanotechnological Methods for Increasing the Bioavailability of Curcumin; A Review

  2017cites this paper
• Antimutagenic and cancer preventive potential of culinary spices and their bioactive compounds

  2017cites this paper
• Raw turmeric and pure curcumin: a comparison of embryonic cytotoxicity in zebrafish

  2017cites this paper
• Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.

  2016cites this paper
• Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?

  2016cites this paper
• Cancer chemoprevention by dietary phytochemicals: Epidemiological evidence.

  2016cites this paper
• Curcumin and Resveratrol in the Management of Cognitive Disorders: What Is the Clinical Evidence?

  2016cites this paper
• Drug Metabolism and Oxidative Stress: Cellular Mechanism and New Therapeutic Insights

  2016cites this paper
• Phytomedicine-Modulating oxidative stress and the tumor microenvironment for cancer therapy.

  2016cites this paper
• Upregulation of cugbp2 increases response of pancreatic cancer cells to chemotherapy

  2016cites this paper
• Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives.

  2016cites this paper
• Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells.

  2016cites this paper
• C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis

  2016cites this paper
• Cancer chemoprevention by dietary phytochemicals: Epidemiological evidence.

  2016cites this paper
• Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro

  2016cites this paper
• Curcumin AntiCancer Studies in Pancreatic Cancer

  2016cites this paper
• Phytochemicals as Complementary and Alternative Therapeutic Formulations with Potential pro- Apoptotic Effects on Various Cancerous Cell Lines: A Literature Survey

  2016cites this paper
• Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment.

  2015cites this paper
• Therapeutic effects of curcumin on the functional disturbances and oxidative stress induced by renal ischemia/reperfusion in rats

  2015cites this paper